TD Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.94M | Buy |
|
|||||
|
2025
Q1 | $4.2M | Buy |
|
|||||
|
2024
Q4 | $5.42M | Buy |
|
|||||
|
2024
Q3 | $7.2M | Buy |
|
|||||
|
2024
Q2 | $4.16M | Buy |
|
|||||
|
2024
Q1 | $3.52M | Buy |
|
|||||
|
2023
Q4 | $1.95M | Sell |
|
|||||
|
2023
Q3 | $2.79M | Buy |
|
|||||
|
2023
Q2 | $2.49M | Sell |
|
|||||
|
2023
Q1 | $2.03M | Sell |
|
|||||
|
2022
Q4 | $2.76M | Buy |
|
|||||
|
2022
Q3 | $2.76M | Sell |
|
|||||
|
2022
Q2 | $3.57M | Sell |
|
|||||
|
2022
Q1 | $4.28M | Buy |
|
|||||
|
2021
Q4 | $5.46M | Sell |
|
|||||
|
2021
Q3 | $6.4M | Hold |
|
|||||
|
2021
Q2 | $6.47M | Sell |
|
|||||
|
2021
Q1 | $8.04M | Buy |
|
|||||
|
2020
Q4 | $11.2M | Buy |
|
|||||
|
2020
Q3 | $3.54M | Buy |
|
|||||
|
2020
Q2 | $1.39M | Buy |
|
|||||
|
2020
Q1 | $573K | Buy |
|
|||||
|
2019
Q4 | $418K | Hold |
|
|||||
|
2019
Q3 | $368K | Sell |
|
|||||
|
2019
Q2 | $509K | Buy |
|
|||||
|
2019
Q1 | $543K | Buy |
|
|||||
|
2018
Q4 | $473K | Buy |
|
|||||
|
2018
Q3 | $487K | Buy |
|
|||||
|
2018
Q2 | $250K | Hold |
|
|||||
|
2018
Q1 | $323K | Buy |
|